Actress Nastasya Samburskaya recently weighed in on the topic of antidepressants via Instagram, a platform where she has a sizable following. Her post did not explicitly name the singer Glukoza, whose real name is Natalia Chistyakova-Ionova, but readers and followers inferred a reference to the star’s public episode after a concert in Krasnoyarsk. The online chatter around Samburskaya’s commentary highlighted a broader public conversation about mental health medications, their effects, and how they are perceived in the glare of celebrity gossip.
In a comment, Samburskaya offered her perspective in a way that aimed to reassure readers about antidepressants. She wrote that these medications can improve quality of life, help restore taste for life, and relieve anxiety. She also cautioned against rejecting treatment, noting that many lives, careers, and families have benefited from proper medical intervention. The actress urged anyone facing similar concerns to seek a prescription and treatment plan from a neurologist or psychiatrist, emphasizing professional guidance over rumors and sensational narratives.
Responses to the post varied. One admirer suggested that Chistyakova-Ionova might be coping with a grave personal loss, such as the death of a grandmother, and that dosage issues could potentially contribute to unusual behavior. Samburskaya dismissed that line of reasoning as unfounded, pointing to documented side effects of antidepressants and sleep aids but without offering direct commentary on the Krasnoyarsk incident. Her reply underscored a distinction between legitimate medical explanations and speculative theories circulating in social media comments.
Reportage about the Krasnoyarsk event, dated July 20, described the singer’s performance as shaky. According to coverage from Mash, the episode drew criticism from the audience, who felt the performance did not meet expectations. The coverage suggested that the singer had reportedly relied on antidepressants and sleeping pills prescribed for stress, and that such medication use may have influenced the onstage delivery. This narrative fueled ongoing public discussion about how medical treatments intersect with high-pressure public appearances and the expectations placed on performers in demanding live settings.
In the wake of the Krasnoyarsk incident, there were subsequent public statements and commentaries involving figures linked to the controversy, including a figure named Galustian who addressed Glukoza in the context of the broader scandal. The discourse around these interactions illustrates how celebrity disputes can quickly morph into broader debates about medication, responsibility, and perception in the entertainment industry. The episode also highlights how social media amplifies interpretations of a celebrity’s health choices and performance, sometimes overshadowing the individual’s own voice and medical context.